Tweet
ARMENIA UNDER AZERBAIJANI BIOTERRORISM THREAT?
PanARMENIAN.Net
March 29, 2012 - 12:48 AMT
PanARMENIAN.Net - Vitreous body with Azerbaijani labeling was
discovered in Armenia's pharmacies.
This became possible only because Armenian government simplified the
import procedure, Samvel Zakaryan, chairman of Armenia's Medicine
Producers and Importers Union of Armenia (MPI Union) told a press
conference in Yerevan.
Amendments introduced to government's prior decree "On approval of
medicine import and export regulations" of March 2001 resulted in
emergence of fake drugs on Armenian market.
Due to these amendments, importers got an opportunity to sell
medication on the market without registering it in the relevant
research center, with no responsibility assumed with regard to
medicine's production location, its components and the country it
was aimed for.
"The vitreous body was produced in Belarus for Azerbaijan; besides,
it could have been imported to Armenia, or purchased in Azerbaijan
and then brought to Armenia," Zakaryan said.
In this context, Zakaryan deems simplification of drug import
procedures unacceptable in Armenia. "We are concerned about this
because the drugs are not registered; furthermore, there is a chance
of potential biological terrorism," he emphasized.
Head of MPI Union further added that some people availed themselves
of this "favorable" situation and started to produce fake medication;
for this, they were called to account.
From: Emil Lazarian | Ararat NewsPress
PanARMENIAN.Net
March 29, 2012 - 12:48 AMT
PanARMENIAN.Net - Vitreous body with Azerbaijani labeling was
discovered in Armenia's pharmacies.
This became possible only because Armenian government simplified the
import procedure, Samvel Zakaryan, chairman of Armenia's Medicine
Producers and Importers Union of Armenia (MPI Union) told a press
conference in Yerevan.
Amendments introduced to government's prior decree "On approval of
medicine import and export regulations" of March 2001 resulted in
emergence of fake drugs on Armenian market.
Due to these amendments, importers got an opportunity to sell
medication on the market without registering it in the relevant
research center, with no responsibility assumed with regard to
medicine's production location, its components and the country it
was aimed for.
"The vitreous body was produced in Belarus for Azerbaijan; besides,
it could have been imported to Armenia, or purchased in Azerbaijan
and then brought to Armenia," Zakaryan said.
In this context, Zakaryan deems simplification of drug import
procedures unacceptable in Armenia. "We are concerned about this
because the drugs are not registered; furthermore, there is a chance
of potential biological terrorism," he emphasized.
Head of MPI Union further added that some people availed themselves
of this "favorable" situation and started to produce fake medication;
for this, they were called to account.
From: Emil Lazarian | Ararat NewsPress